NED Medical, Inc.
PrivateLast Round
Series A
Feb 19, 2026
Est. Valuation
$31M
Total Funding Raised
$8.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NED Medical, Inc. is a biotechnology company that develops oncology embolization therapies, including its proprietary CombiSphere technology for liver cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NED Medical, Inc. Comparables
Compare NED Medical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ABK Biomedical | 84% | |
| Sirtex Medical | 80% | |
| Cortex, Inc. | 79% | |
NED Medical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 19, 2026 | ||||
| Seed | Aug 29, 2023 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 123% MoM, reaching 1.9K.
- Feb 19, 2026
Raised $8M in Series A funding.
NED Medical, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NED Medical, Inc.'s valuation, stock price, and market status.